Nachrichten zur ANI Pharmaceuticals Aktie

Moving Average Crossover Alert: ANI Pharmaceuticals

ANI Pharmaceuticals could be a stock to avoid from a technical perspective, as the firm is seeing unfavorable trends on…

ANI Pharmaceuticals to Present at Evercore ISI 2nd Annual HealthCONx Conference

BAUDETTE, Minn. , Nov. 26, 2019 /PRNewswire/ -- ANI Pharmaceuticals, Inc. (NASDAQ: ANIP) will present…

ANI Pharmaceuticals (ANIP) Lags Q3 Earnings and Revenue Estimates

ANI (ANIP) delivered earnings and revenue surprises of -16.89% and -10.25%, respectively, for the quarter ended September 2019. Do the…

ANI Pharmaceuticals Reports Third Quarter Results

BAUDETTE, Minn. , Nov. 6, 2019 /PRNewswire/ --...…

ANI Announces Plans to Launch Bretylium Tosylate Injection, USP 500mg/10ml (50mg/ml) for Ventricular Arrhythmias

BAUDETTE, Minn. , Oct. 31, 2019 /PRNewswire/ -- ANI Pharmaceuticals, Inc. ("ANI") (Nasdaq: ANIP) today…

ANI Pharmaceuticals Schedules Conference Call to Discuss Third Quarter and Year-to-Date 2019 Financial Results

BAUDETTE, Minn. , Oct. 30, 2019 /PRNewswire/ -- ANI Pharmaceuticals, Inc. (NASDAQ: ANIP) announced today…

ANI Pharmaceuticals announces the launch of ANI Global Source, its contract development and manufacturing business

BAUDETTE, Minn. , Oct. 29, 2019 /PRNewswire/ -- ANI Pharmaceuticals, Inc. ("ANI") (Nasdaq: ANIP), an…

ANI Announces Positive Clinical Results from Cortrophin® Gel Cortisol Response Study

BAUDETTE, Minn. , Oct. 3, 2019 /PRNewswire/ -- ANI Pharmaceuticals, Inc. ("ANI") (Nasdaq: ANIP) today…

ANI Pharmaceuticals Announces Launch of Aspirin and Extended Release Dipyridamole Capsules, 25mg/200mg

BAUDETTE, Minn. , Oct. 2, 2019 /PRNewswire/ -- ANI Pharmaceuticals, Inc. ("ANI") (Nasdaq: ANIP)…

ANI Pharmaceuticals Announces Launch of Vancomycin Hydrochloride for Oral Solution USP, 250mg/5mL

BAUDETTE, Minn. , Sept. 11, 2019 /PRNewswire/ -- ANI Pharmaceuticals, Inc. ("ANI") (Nasdaq: ANIP) today…

ANI Pharmaceuticals, Inc. (ANIP) CEO Arthur Przybyl on Q2 2019 Results - Earnings Call Transcript

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…

ANI Pharmaceuticals Inc (ANIP) Q2 2019 Earnings Call Transcript

ANIP earnings call for the period ending June 30, 2019....…

ANI Pharmaceuticals (ANIP) Q2 Earnings Surpass Estimates

ANI (ANIP) delivered earnings and revenue surprises of 11.63% and -2.24%, respectively, for the quarter ended June 2019. Do the…

ANI Pharmaceuticals Reports Second Quarter Results

BAUDETTE, Minn. , Aug. 7, 2019 /PRNewswire/ --...…

ANI Pharmaceuticals Schedules Conference Call to Discuss Second Quarter and Year-to-Date 2019 Financial Results

BAUDETTE, Minn. , July 31, 2019 /PRNewswire/ -- ANI Pharmaceuticals, Inc. (NASDAQ: ANIP) announced…

ANI Pharmaceuticals Announces Launch of Ranitidine Capsules

BAUDETTE, Minn. , June 25, 2019 /PRNewswire/ -- ANI Pharmaceuticals, Inc. ("ANI") (Nasdaq: ANIP)…

ANI Pharmaceuticals Announces Approval of Vancomycin Hydrochloride for Oral Solution USP, 250mg/5ml

BAUDETTE, Minn. , June 20, 2019 /PRNewswire/ -- ANI Pharmaceuticals, Inc. ("ANI") (Nasdaq: ANIP)…

ANI Pharmaceuticals Expands Generic Pipeline with Acquisition of Seven Development Stage Drug Products from Coeptis Pharmaceuticals, Inc.

BAUDETTE, Minn. , June 18, 2019 /PRNewswire/ -- ANI Pharmaceuticals, Inc. ("ANI") (Nasdaq: ANIP) today…

ANI Pharmaceuticals to Present at Raymond James Life Sciences and MedTech Conference

BAUDETTE, Minn. , June 12, 2019 /PRNewswire/ -- ANI Pharmaceuticals, Inc. (NASDAQ: ANIP) will…

ANI Pharmaceuticals Inc (ANIP) Q1 2019 Earnings Call Transcript

ANIP earnings call for the period ending March 31, 2019....…

ANI Pharmaceuticals Reports First Quarter 2019 Results and Reaffirms Guidance

BAUDETTE, Minn. , May 9, 2019 /PRNewswire/ --...…

ANI Pharmaceuticals Schedules Conference Call to Discuss First Quarter 2019 Financial Results

BAUDETTE, Minn. , May 2, 2019 /PRNewswire/ -- ANI Pharmaceuticals, Inc. (NASDAQ: ANIP) announced…

ANI Pharmaceuticals (ANIP) Dips More Than Broader Markets: What You Should Know

ANI Pharmaceuticals (ANIP) closed at $69.66 in the latest trading session, marking a -0.49% move from the prior day....…

Zacks.com featured expert Kevin Matras highlights: Advanced Emissions Solutions, Verint Systems, Great Lakes Dredge & Dock, ANI Pharmaceuticals and ACI Worldwide

Zacks.com featured expert Kevin Matras highlights: Advanced Emissions Solutions, Verint Systems, Great Lakes Dredge & Dock, ANI Pharmaceuticals and ACI…

ANI Pharmaceuticals (ANIP) Stock Sinks As Market Gains: What You Should Know

In the latest trading session, ANI Pharmaceuticals (ANIP) closed at $68.88, marking a -0.17% move from the previous day....…

ANI Pharmaceuticals Expands Injectable Portfolio with Distribution Agreement for FDA Approved Injectable Product

BAUDETTE, Minn. , April 15, 2019 /PRNewswire/ -- ANI Pharmaceuticals, Inc. ("ANI" or the "Company")…

ANI Pharmaceuticals (ANIP) Outpaces Stock Market Gains: What You Should Know

In the latest trading session, ANI Pharmaceuticals (ANIP) closed at $69.44, marking a +1.71% move from the previous day....…

Zacks.com featured expert Kevin Matras highlights: Herc, ANI Pharmaceuticals, Kamada, SP Plus and SkyWest

Zacks.com featured expert Kevin Matras highlights: Herc, ANI Pharmaceuticals, Kamada, SP Plus and SkyWest...…

ANI Pharmaceuticals (ANIP) Stock Sinks As Market Gains: What You Should Know

In the latest trading session, ANI Pharmaceuticals (ANIP) closed at $70.39, marking a -0.13% move from the previous day....…

Moving Average Crossover Alert: ANI Pharmaceuticals

ANI Pharmaceuticals, Inc. (ANIP) is looking like an interesting pick from a technical perspective, as the company is seeing favorable…

ANI Pharmaceuticals Announces Two Generic Product Launches

BAUDETTE, Minn. , March 27, 2019 /PRNewswire/ -- ANI Pharmaceuticals, Inc. ("ANI" or the "Company")…

ANI Pharmaceuticals (ANIP) Q4 2018 Earnings Conference Call Transcript

ANIP earnings call for the period ending December 31, 2018....…

ANI Pharmaceuticals Inc. (ANIP) CEO Arthur Przybyl on Q4 2018 Results - Earnings Call Transcript

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…

ANI Pharmaceuticals Reports Record Full Year and Fourth Quarter 2018 Results and Provides 2019 Guidance

BAUDETTE, Minn. , Feb. 27, 2019 /PRNewswire/ --...…

Is ANI Pharmaceuticals a Great Stock for Value Investors-

Let???s see if ANI Pharmaceuticals (ANIP) stock is a good choice for value-oriented investors right now from multiple angles....…

ANI Pharmaceuticals, Inc. (ANIP) CEO Arthur Przybyl on Q3 2018 Results - Earnings Call Transcript

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…

ANI Pharmaceuticals Inc (ANIP) Q3 2018 Earnings Conference Call Transcript

ANIP earnings call for the period ending September 30, 2018....…

ANI Pharmaceuticals (ANIP) Q3 Earnings and Revenues Surpass Estimates

ANI (ANIP) delivered earnings and revenue surprises of 5.74% and 0.20%, respectively, for the quarter ended September 2018. Do the…

ANI Pharmaceuticals to Present at New Time at the Canaccord Genuity 38th Annual Growth Conference

BAUDETTE, Minn. , Aug. 8, 2018 /PRNewswire/ -- ANI Pharmaceuticals, Inc. (NASDAQ: ANIP) announced today…

ANI Pharmaceuticals (ANIP) CEO Arthur Przybyl on Q2 2018 Results - Earnings Call Transcript

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…

ANI Pharmaceuticals (ANIP) Lags Q2 Earnings and Revenue Estimates

ANI (ANIP) delivered earnings and revenue surprises of -13.08% and -6.77%, respectively, for the quarter ended June 2018. Do the…

ANI Pharmaceuticals (ANIP) CEO Arthur Przybyl on Q1 2018 Results - Earnings Call Transcript

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…

BRIEF-ANI Pharmaceuticals Reports Q1 GAAP Earnings Per Share $0.19

* ANI PHARMACEUTICALS REPORTS FIRST QUARTER 2018 RESULTS AND REAFFIRMS GUIDANCE...…

Ani Pharmaceuticals to buy generic products from Amneal and Impax

Ani Pharmaceuticals has agreed to acquire a portfolio of generic products and other assets from Amneal Pharmaceuticals and Impax Laboratories…

BRIEF-Ani Pharmaceuticals To Acquire Generic Products And Assets From Amneal/Impax

* ANI PHARMACEUTICALS SIGNS DEFINITIVE AGREEMENTS TO ACQUIRE GENERIC PRODUCTS AND ASSETS FROM AMNEAL/IMPAX...…

ANI Pharmaceuticals Signs Definitive Agreements to Acquire Generic Products and Assets from Amneal/Impax

BAUDETTE, Minn., April 27, 2018 /PRNewswire/ -- ANI Pharmaceuticals, Inc. ("ANI") (Nasdaq: ANIP) today announced that it has signed definitive…

ANI Pharmaceuticals Announces Approval of Morphine Sulfate Oral Solution

BAUDETTE, Minn., April 18, 2018 /PRNewswire/ -- ANI Pharmaceuticals, Inc. ("ANI") (Nasdaq: ANIP) today announced that it has received approval…

BRIEF-ANI Acquires 23 ANDAs From IDT Australia

April 4 (Reuters) - ANI Pharmaceuticals Inc - Deal For $2.6 Mln And A Limited Single :...…

Should Value Investors Pick ANI Pharmaceuticals (ANIP) Stock-

Lets put ANI Pharmaceuticals (ANIP) stock into this equation and find out if it is a good choice for value-oriented…

ANI Pharmaceuticals (ANIP) Presents At Raymond James 39th Annual Institutional Investors Conference - Slideshow

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…